- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on High Risk Prostate Carcinoma
Total 1593 results
-
Qilu Hospital of Shandong UniversityRecruitingProstate CarcinomaChina
-
Turku University HospitalGE Healthcare; Blue Earth DiagnosticsCompletedProstate CarcinomaFinland
-
Wuhan Mental Health CentreHealth Commission of Hubei ProvinceCompletedHigh Risk Group of SchizophreniaChina
-
University of California, San DiegoNational Institute of Mental Health (NIMH)UnknownSchizophrenia | Psychosis | Clinical High Risk | ProdromalUnited States, Mexico
-
University of UtahTerminatedHigh Risk Hematologic MalignanciesUnited States
-
Emory UniversityTerminatedRecurrent Solid Tumors | High Risk Solid TumorsUnited States
-
Roswell Park Cancer InstituteNational Comprehensive Cancer NetworkRecruitingCastration-Resistant Prostate Carcinoma | Stage IV Prostate Cancer AJCC v8 | Stage IVA Prostate Cancer AJCC v8 | Stage IVB Prostate Cancer AJCC v8United States
-
University of AlbertaRecruiting
-
Rahul AggarwalNational Cancer Institute (NCI)RecruitingProstate Cancer | Advanced Prostate CarcinomaUnited States
-
University Hospital, RouenRecruitingMetastatic Prostate AdenocarcinomaFrance
-
Nicholas MitsiadesWithdrawnProstate CarcinomaUnited States
-
Ronald HoffmanNational Cancer Institute (NCI); Roche Pharma AG; Myeloproliferative Disorders-Research...CompletedHigh Risk Polycythemia Vera | High Risk Essential ThrombocythemiaUnited States, Italy
-
Jonsson Comprehensive Cancer CenterNot yet recruitingProstate Carcinoma | Stage IVB Prostate Cancer American Joint Committee on Cancer (AJCC) v8United States
-
Andrei IagaruNational Cancer Institute (NCI)CompletedStage II Prostate Adenocarcinoma | Stage III Prostate AdenocarcinomaUnited States
-
M.D. Anderson Cancer CenterRecruitingProstate Carcinoma | Stage IIIA Prostate Cancer AJCC v8 | Stage IIIB Prostate Cancer AJCC v8 | Stage IIC Prostate Cancer AJCC v8 | Stage III Prostate Cancer AJCC v8 | Stage IIIC Prostate Cancer AJCC v8 | Stage IVA Prostate Cancer AJCC v8United States
-
University of WashingtonAstraZenecaTerminatedCastration-Resistant Prostate Carcinoma | Prostate AdenocarcinomaUnited States
-
University Medical Center GroningenCompleted
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingBiochemically Recurrent Prostate Carcinoma | Stage IV Prostate Cancer AJCC v8 | Stage IVA Prostate Cancer AJCC v8 | Stage IVB Prostate Cancer AJCC v8 | Metastatic Prostate AdenocarcinomaUnited States
-
OHSU Knight Cancer InstituteMovember FoundationCompletedCancer Survivor | Prostate CarcinomaUnited States
-
Jonsson Comprehensive Cancer CenterJanssen Inc.Active, not recruitingRecurrent Prostate Carcinoma | Stage IVB Prostate Cancer AJCC v8 | Metastatic Prostate Adenocarcinoma | Prostate Adenocarcinoma With Focal Neuroendocrine DifferentiationUnited States
-
Case Comprehensive Cancer CenterCompletedAdenocarcinoma of the ProstateUnited States
-
AmgenCompletedHypercholesterolemia and High Risk for Cardiovascular EventsJapan
-
RenJi HospitalRecruitingAspirin as Adjuvant Therapy in Patients With Surgically Treated High Risk Renal Cell CarcinomaChina
-
IRCCS San RaffaeleRecruitingLocalized Prostate CarcinomaItaly
-
Robert Flavell, MD, PhDBristol-Myers Squibb; U.S. Army Medical Research Acquisition ActivityRecruitingProstate Cancer | Localized Prostate CarcinomaUnited States
-
University Health Network, TorontoCompletedProstate Cancer (Adenocarcinoma)Canada
-
Emory UniversityNational Cancer Institute (NCI); Xencor, Inc.RecruitingStage IVB Prostate Cancer AJCC v8 | Metastatic Prostate Adenocarcinoma | Castration-Sensitive Prostate CarcinomaUnited States
-
Zhao ChongCancer Institute and Hospital, Chinese Academy of Medical Sciences; Jiangxi... and other collaboratorsCompletedLocal Advanced High Risk Nasopharyngeal CarcinomaChina
-
Schrödinger, Inc.RecruitingAcute Myeloid Leukemia | High-Risk and Very High-Risk Myelodysplastic SyndromesUnited States
-
National Cancer Institute (NCI)Active, not recruitingRecurrent Prostate Carcinoma | Stage IIA Prostate Cancer AJCC v7 | Stage III Prostate Cancer AJCC v7 | Stage I Prostate Cancer AJCC v7 | Stage IIB Prostate Cancer AJCC v7United States, Ireland
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedCastration-Resistant Prostate Carcinoma | Prostate Adenocarcinoma | Stage IV Prostate Cancer AJCC v8 | Metastatic Malignant Neoplasm in the Bone | Stage IVA Prostate Cancer AJCC v8 | Stage IVB Prostate Cancer AJCC v8United States
-
University of California, San FranciscoJanssen PharmaceuticalsActive, not recruitingCastration-Resistant Prostate Carcinoma | PSA Progression | Stage IV Prostate Adenocarcinoma AJCC v7 | Castration Levels of TestosteroneUnited States
-
Mayo ClinicNational Cancer Institute (NCI)RecruitingImmunological Effects of Vitamin D Replacement Among Black/African American Prostate Cancer PatientsStage IV Prostate Cancer AJCC v8 | Localized Prostate CarcinomaUnited States
-
UNICANCERInstitut Bergonié; National Cancer Institute, France; Institut du Cancer de Montpellier...CompletedChemotherapy | Castration-resistant Prostate Cancer | Prostate Carcinoma | Circulating Tumor CellsFrance
-
Centre for Addiction and Mental HealthUnknownClinical High Risk for PsychosisCanada
-
University of California, DavisGinger.ioCompletedPsychosis | Clinical High Risk for PsychosisUnited States
-
Instituto de Assistencia Medica ao Servidor Publico...University of Sao Paulo; Federal University of São Paulo; Hospital Padre Albino...CompletedPostoperative Complications | Hemodynamics Instability | Goal-directed Fluid Therapy | High-risk Surgery | Pulse-pressure Variation
-
University of Erlangen-Nürnberg Medical SchoolUnknownRecurrence | Prostate Cancer
-
University of PittsburghSubstance Abuse and Mental Health Services Administration (SAMHSA)RecruitingPsychological | Clinical High-RiskUnited States
-
Sun Yat-sen UniversityJiangsu Hansoh Pharmaceutical Co., Ltd.UnknownSolid Tumor Patients Receiving High Emetic Risk Multi-day ChemotherapyChina
-
Beth Israel Deaconess Medical CenterDana-Farber Cancer Institute; Puma Biotechnology, Inc.WithdrawnProstate Cancer | Castration-resistant Prostate Cancer | Prostate Cancer Metastatic | Metastatic Prostate AdenocarcinomaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingMetastatic Clear Cell Renal Cell Carcinoma | Castration-Resistant Prostate Carcinoma | Metastatic Prostate Carcinoma | Stage IV Prostate Cancer AJCC v8 | Stage IV Renal Cell Cancer AJCC v8 | Metastatic Malignant Solid Neoplasm | Metastatic Urothelial Carcinoma | Stage IVA Prostate Cancer AJCC v8 | Stage... and other conditionsUnited States
-
InSightecUnknownLocalized Intermediate Risk Prostate LesionsUnited States
-
Jiangsu HengRui Medicine Co., Ltd.Active, not recruitingAdjuvant Therapy in Patients With Hepatocellular Carcinoma (HCC) at High Risk of Recurrence After Curative Resection or AblationChina
-
University of Michigan Rogel Cancer CenterNovartis; Aventis PharmaceuticalsCompletedHormone-Refractory Prostate CancerUnited States
-
Consorci Sanitari de TerrassaRecruitingProstate Adenocarcinoma | Prostate Cancer AdenocarcinomaSpain
-
Ronald HoffmanNational Cancer Institute (NCI); Roche Pharma AG; Myeloproliferative Disorders-Research...CompletedHigh Risk Polycythemia Vera | High Risk Essential ThrombocythemiaUnited States, Italy, United Kingdom, France
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingStage IV Prostate Cancer AJCC v8 | Stage IVA Prostate Cancer AJCC v8 | Stage IVB Prostate Cancer AJCC v8 | Metastatic Prostate Adenocarcinoma | Castration-Sensitive Prostate CarcinomaUnited States
-
AmgenActive, not recruitingMetastatic Castration-resistant Prostate CancerUnited States
-
Calibr, a division of Scripps ResearchTerminatedMetastatic Castration-Resistant Prostate AdenocarcinomaUnited States